IPF – Mortality

IPF – a rare disease but with a higher mortality than many common malignancies

The precise incidence and prevalence of IPF is difficult to determine because uniform diagnostic criteria have not always been used.2 However, several sources indicate an estimated incidence of IPF of 4.6-7.4/100,000.8,9,10 This suggests that approximately 30,000 – 35,000 new patients will be diagnosed with IPF in the 27 EU countries each year.2

IPF is more common in men than in women and is usually diagnosed between the ages of 40 and 80 years.12

IPF is an inevitably fatal lung disease, with an estimated median survival time of 2 to 5 years following diagnosis. The mortality rate from IPF is higher than mortality rates from a number of malignancies, including colon cancer, multiple myeloma and bladder cancer. The 5-year survival for IPF ranges between 20-40%.13

Comparison of the 5-year survival rate for IPF and common malignancies

Bjoraker JA, Ryu JH, Edwin MK, et al. Am J Respir Crit Care Med 1998;157:199-20313

You are now leaving the InterMune website. If you would like to continue, click Continue. Otherwise, click Cancel.

Arbetar du inom sjukvården?
Ja Nej